SELLAS Life Sciences Group, Inc. (SLS)
8.56
+0.44
(+5.42%)
USD |
NASDAQ |
May 27, 16:00
8.64
+0.08
(+0.93%)
After-Hours: 18:40
SELLAS Life Sciences Group Free Cash Flow : -28.16M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rezolute, Inc. | -73.48M |
| Krystal Biotech, Inc. | 237.38M |
| Spero Therapeutics, Inc. | 7.242M |
| Recursion Pharmaceuticals, Inc. | -328.08M |
| Whitehawk Therapeutics, Inc. | -107.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.846M |
| Cash from Financing (Quarterly) | 44.15M |
| Free Cash Flow Per Share (Quarterly) | -0.0513 |
| Free Cash Flow to Equity (Quarterly) | -8.716M |
| Free Cash Flow to Firm (Quarterly) | -8.846M |
| Free Cash Flow Yield | -2.47% |